STOCK TITAN

BODY AND MIND INC - BMMJ STOCK NEWS

Welcome to our dedicated page for BODY AND MIND news (Ticker: BMMJ), a resource for investors and traders seeking the latest updates and insights on BODY AND MIND stock.

Body and Mind Inc. (BMMJ) is a diversified, operation-focused cannabis company with a presence in multiple states, including Arkansas, California, Illinois, and pending operations in New Jersey. The company is known for its retail operations, craft cultivation, and processing capabilities, aimed at delivering high-quality cannabis products to consumers.

Recently, Body and Mind has been making significant strides in its corporate strategy. The company announced the planned divestment of its Ohio processing operation and license, with funds earmarked to reduce debt and support the development of new market opportunities in Illinois and New Jersey. The construction of the Body and Mind branded dispensary in Lynnwood, Illinois, has commenced, with significant progress toward building permits and groundwork. Additionally, the company has finalized building plans for a new dispensary in Lawrenceville, New Jersey, and received local authorization, with state approval in process.

The sale of the Ohio dispensary, which fetched $8.225 million in cash (with an additional $2.5 million in potential contingent proceeds), has allowed Body and Mind to repay its $7.33 million debt. This early repayment significantly lowers the company's annual interest expenses by approximately $1 million.

Financially, Body and Mind reported an annual revenue of $22.8 million for the fiscal year ended July 31, 2023. The company's efforts to streamline assets and operations have bolstered its financial stability, with a focus on high-return projects in Illinois and New Jersey. The company has also announced updates on its Nevada operations and continues to explore new market opportunities as the cannabis industry matures.

Body and Mind Inc. is committed to increasing its market share through exceptional customer service and operational efficiency. The company prioritizes return on investment and is poised for significant future shareholder value creation as it expands its retail footprint and operational capabilities.

Rhea-AI Summary
Body and Mind Inc. closes Ohio dispensary transaction and repays debt
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.11%
Tags
none
-
Rhea-AI Summary
Body and Mind Inc. provides corporate update, including divestment of Ohio processing operation, construction of Lynnwood dispensary in Illinois, and finalization of building plans for New Jersey dispensary.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
25%
Tags
none
-
Rhea-AI Summary
Body and Mind Inc. announces the sale of its Ohio dispensary to FarmaceuticalRX, LLC for a total consideration of US$8.225 million in cash proceeds at closing with an additional US$2.5 million in potential contingent proceeds. The sale will improve the company's balance sheet and provide flexibility for strategic growth initiatives in New Jersey and Illinois.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
25%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20%
Tags
none
News
Rhea-AI Summary

Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) has announced significant progress in its operations, including the upcoming launch of a Body and Mind-branded dispensary in Markham, Illinois. The company has received a temporary occupancy permit and plans to open within weeks. Concurrently, Body and Mind is divesting its dispensary in Michigan through a stock purchase agreement, which involves a third party assuming the long-term lease and inventory. The company, focused on enhancing its market share, recognizes these endeavors as crucial for future growth. Its broader strategy includes operating dispensaries in Illinois and New Jersey, aiming to drive profitability and enhance shareholder value.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Body and Mind Inc. (OTCQB: BMMJ) reported $7.7 million in revenue for Q2 FY 2023, slightly down from $7.8 million in Q1 FY 2023. The company incurred a net loss of $2.7 million, improving from $3.0 million previously. Gross profit rose to $2.26 million, up from $1.6 million. The company advanced its operations in Illinois and New Jersey and is set to open its first Illinois dispensary in April 2023. Significant wholesale price improvements in Nevada and Ohio contributed positively to financial results.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-20%
Tags
-
Rhea-AI Summary

Body and Mind Inc. (OTCQB: BMMJ) has provided a corporate update regarding the construction of two new dispensaries in Illinois. The Markham location is expected to open by late April, strategically positioned in a high-traffic area with over 400,000 vehicles passing daily. The second dispensary in Southern Chicago has received community approval and is in the process of obtaining building permits. In 2022, Illinois cannabis sales reached $1.55 billion with only 113 dispensaries serving nearly 13 million people. Body and Mind is poised to enhance its presence in a largely underserved market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Body and Mind Inc. (CNSX: BAMM; OTCQB: BMMJ) announced the appointment of Josh Rosen to its board of directors, enhancing its leadership as it expands into key markets like Illinois and New Jersey. Rosen, managing partner at Bengal Capital, previously led 4Front Ventures Corp., growing its operational focus and market presence. CEO Michael Mills expressed confidence in Rosen's expertise to drive value in the evolving cannabis sector. The company also acknowledged the contributions of Dong Shim, who remains as CFO, ensuring continuous leadership during this transition.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management

FAQ

What is the current stock price of BODY AND MIND (BMMJ)?

The current stock price of BODY AND MIND (BMMJ) is $0.0088 as of November 22, 2024.

What is the market cap of BODY AND MIND (BMMJ)?

The market cap of BODY AND MIND (BMMJ) is approximately 1.6M.

What is Body and Mind Inc.?

Body and Mind Inc. (BMMJ) is a multi-state operations-focused cannabis company with retail operations, craft cultivation, and processing capabilities.

What recent changes has Body and Mind Inc. announced?

The company announced the divestment of its Ohio processing operation and license, along with the construction of new dispensaries in Illinois and New Jersey.

How did Body and Mind Inc. benefit from the sale of the Ohio dispensary?

The sale fetched $8.225 million in cash, allowing the company to repay its $7.33 million debt and significantly reduce annual interest expenses.

What are the company’s current projects?

Current projects include the construction of dispensaries in Lynnwood, Illinois, and Lawrenceville, New Jersey, and divesting from Nevada operations.

How did Body and Mind Inc. perform financially in FY2023?

The company reported an annual revenue of $22.8 million for the fiscal year ended July 31, 2023.

What markets is Body and Mind Inc. focusing on?

The company is focusing on expanding its retail operations in Illinois and New Jersey while maintaining its presence in Arkansas and California.

What is the company’s strategy for future growth?

Body and Mind Inc. aims to increase market share through customer satisfaction and operational efficiency while prioritizing high-return projects.

Has Body and Mind Inc. received any licenses in New Jersey?

Yes, the company has received an Annual Class 5 Cannabis Retailer license for its Lawrenceville, New Jersey dispensary.

What are the company’s core values?

Body and Mind Inc. focuses on operational efficiency, customer satisfaction, and maximizing return on investment.

Where can more information about Body and Mind Inc. be found?

More information can be found on the company's website at www.bodyandmind.com.

BODY AND MIND INC

OTC:BMMJ

BMMJ Rankings

BMMJ Stock Data

1.63M
127.80M
8.16%
5.3%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Vancouver